The Personal Patient Profile Decision Support for Patients With Bladder Cancer
Completed · Not applicable
Conditions studied: Bladder Cancer
In brief
There is a pressing need to develop a personalized, value-based decisional tool for bladder cancer patients undergoing radical cystectomy (bladder removal) and urinary diversion to help them with communication with the physicians, shared decision making, and preparation for disease-management and follow-up care. The proposed intervention, the Personal Patient Profile - Bladder Cancer (P3-BC), will be the first intervention to address these issues. Results of this pilot randomized feasibility study will provide evidence of the feasibility and acceptability of the P3-BC and will guide further refinement of the tool for a larger experimental trial, with potential dissemination of the program via the Internet and hand-held computing devices.
Key facts
- Study ID
- NCT05033067
- Run by
- Icahn School of Medicine at Mount Sinai
- People needed
- 24
- Starts
- 2021-06-10
- Expected to finish
- 2024-08-31
- Last updated by the study team
- 2026-04-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients: cystectomy for MIBC and NMIBC;
- at least 18 years;
- able to communicate in English; and
- competent to give consent.
You may not qualify if…
- Existence of other cancers or ongoing cancer treatment.
Where it is running
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
- University of Washington — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.